Search
Displaying 541–550 of 624 for “retinal diseases”
-
- Jul 12, 2025
- 11:00 a.m. (EDT)
- Virtual
Foundation EventCRB1 Program Project Award Kickoff Webinar
-
- Oct 4, 2025
- 9:00 a.m. (PDT)
- 7400 Sand Point Way NE, Seattle, WA 98115
Community EventJoin your VisionWalk community! Together, we step closer to fighting blinding diseases.
-
Well-prepared estate plan brings peace of mind—knowing your loved ones are cared for and your wishes will be honored. It also offers a unique opportunity to leave a lasting impact on a cause important to you.
-
Research News
The company is currently enrolling patients in its Phase 2/3 VISTA Clinical Trial.
-
Beacon Stories Wellness
Rob Howden’s journey with AMD and GA truly shows that individuals can take control of their vision loss journey and find strength within their community. His story emphasizes the importance of proactive treatment, taking care of your mental health, and the invaluable support of friends and neighbors.
-
The Mental Health Resource Center serves as a trusted space, offering tools, resources, and connections to help individuals and families manage the unique emotional complexities associated with vision changes.
-
Luxa Reports Vision Improvements in Clinical Trial of its RPE Stem Cell Therapy for Dry AMD
Research NewsPatients with worse vision at trial enrollment had greatest vision improvements.
-
Eye on the Cure Podcast | Episode 82: Aaron Nagiel, MD, PhD
Eye on the CureDr. Nagiel discusses how gene therapy is administered to the retina, the surgery and recovery for patients, and the vision improvements for young patients receiving LUXTURNA, the first FDA-approved gene therapy for the eye or an inherited condition.
-
RD Fund Invests in Perceive Pharma for Development of Neuroprotective Therapies
Research NewsPerceive Pharma is a spin out of Perceive Biotherapeutics.
-
Harriet Finkelstein, Foundation Angel, Passes Away
Foundation NewsThough unaffected by vision loss, she brought great passion to driving the Foundation’s mission.
.png)
